Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis.
Saved in:
| Title: | Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis. |
|---|---|
| Authors: | Merola JF; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Butler DC; Department of Dermatology, University of California, San Francisco., Mark T; LEO Pharma A/S, Ballerup, Denmark., Schneider S; LEO Pharma Inc, Madison, New Jersey., Kim Y; LEO Pharma Inc, Madison, New Jersey., Abuabara K; Department of Dermatology, University of California, San Francisco. |
| Source: | JAMA dermatology [JAMA Dermatol] 2023 Oct 01; Vol. 159 (10), pp. 1119-1123. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
